Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 14/20 | 0.43 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | CALML3 | P27482 | 1/20 | 0.39 |
| ▸ | SDHA | P31040 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23716997 | 1.00 | MAOB (0.44) | MAOBGRM2F10MAOALMNA | |
| SCHEMBL23992000 | 0.84 | MAOB (0.41) | MAOBGRM2F10MAOALMNA | |
| SCHEMBL23991986 | 0.84 | MAOB (0.41) | MAOBGRM2F10MAOALMNA | |
| SCHEMBL23716899 | 0.83 | MAOB (0.60) | MAOBF10MAOALMNAPTGS1 | |
| SCHEMBL23699743 | 0.80 | MAOB (0.51) | MAOBGRM2F10MAOALMNA | |
| SCHEMBL23699742 | 0.80 | MAOB (0.51) | MAOBGRM2F10MAOALMNA | |
| SCHEMBL23699716 | 0.80 | MAOB (0.61) | MAOBF10MAOALMNAPTGS1 | |
| SCHEMBL11969464 | 0.76 | F10 (0.47) | MAOBF10MAOALMNAPTGS1 | |
| SCHEMBL23991995 | 0.75 | MAOB (0.43) | MAOBF10MAOALMNAPTGS1 | |
| SCHEMBL23991985 | 0.75 | MAOB (0.43) | MAOBF10MAOALMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210238151-A1 | OXAZOLIDINONE HYDROXAMIC ACID DERIVATIVES | KUWAIT UNIVERSITY (KW) | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238151-A1 | OXAZOLIDINONE HYDROXAMIC ACID DERIVATIVES | ALOX5, ALOX15, ALOX15B | MAOB 379/4885GRM2 1343/4885F10 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.